Image For Activity Cover
ORN - Hot Topics in Addiction Medicine - Fall 2022 Webinar Series (On-Demand)
Description
This webinar series takes a closer look at the initiation of buprenorphine in the age of fentanyl, managing opioid complexity in individuals with serious illness and the state of harm reduction in the US.

IMPORTANT: Be sure you complete all desired sessions PRIOR to completing the survey and claiming your certificate. You must claim your certifcate for us to report CME.


  1. Trials and Tribulations of ED Initiation of Buprenorphine in the Age of Fentanyl
    Jeanmarie Perrone, MD and Lewis Nelson, MD
  2. Case Studies and Q&A - Trials and Tribulations of ED Initiation of Buprenorphine in the Age of Fentanyl
    Jeanmarie Perrone, MD and Lewis Nelson, MD
  3. Managing Opioid Complexity in Individuals with Serious Illness
    Jessica Merlin, MD 
  4. Case Studies and Q&A: Managing Opioid Complexity in Individuals with Serious Illness
    Jessica Merlin, MD
  5. The State of Harm Reduction in the US: Progress, Barriers, and What's Next.
    Brandon Marshall, PhD
  6. Case Studies and Q&A: The State of Harm Reduction in the US: Progress, Barriers, and What's Next.
    Brandon Marshall, PhD 
Learning Objectives
Attendees should be able to:
  1. Describe the evidence and support for initiation of treatment for opioid use disorder in the emergency department. 
  2. Characterize the barriers and facilitators of initiating buprenorphine in the emergency department.
  3. Identify strategies to implement harm reduction initiatives such as naloxone dispensing and prescribing.

Participants attending this webinar will have increased knowledge and competence in starting buprenorphine in individuals using IMF which will improve outcomes in those who have OUD.  Participants will complete a survey at the end of the webinar to assess if learning objectives were met and if they will incorporate concepts detailed in this webinar into their practice.

Claim Credits & Course Materials

How to claim your credits & download handouts for each webinar:

Under the "Course" tab (or "Content" tab):
  1. Complete the required course materials.
  2. Claim your credits by clicking the "Report Credit" or "Request Credit" button on the right above the course materials.
Accreditation Statements
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Osteopathic Association (AOA) and American Osteopathic Academy of Addiction Medicine (AOAAM). The American Osteopathic Association is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement – Physicians
The American Osteopathic Association designates this enduring activity for a maximum of 6 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Speakers

Lewis Nelson, MD
Rutgers New Jersey Medical School

Lewis S. Nelson, MD, MBA is Professor and Chair of the Department of Emergency Medicine, Chief of Service of the University Hospital Emergency Department, and Chief of the Division of Medical Toxicology at Rutgers New Jersey Medical School, all in Newark, NJ. He is also a Senior Consultant to the New Jersey Poison Information & Education System. He is board certified in emergency medicine, medical toxicology, and addiction medicine. Dr. Nelson is an editor of the medical toxicology textbook Goldfrank’s Toxicologic Emergencies and on the editorial boards of several peer-reviewed journals. He is a member of the board of the American Board of Emergency Medicine and several other academic organizations and is Past President of American College of Medical Toxicology. Dr. Nelson serves as a long-standing consultant to CDC, DHS, and FDA and has worked with numerous professional organizations including ACEP and ASAM. Some of his areas of interest include non-opioid pain relief strategies, opioid overdose and management, addiction and withdrawal management, and health policy focused on issues related to medication safety and substance use.

Jeanmarie Perrone, MD
University of Penn

Jeanmarie Perrone is a Professor in the Department of Emergency Medicine, and the Director of the Penn Center for Addiction Medicine and Policy.  Dr. Perrone has led multiple initiatives in opioid stewardship and leads a program for the ED treatment of Opioid Use Disorder (OUD).  Dr. Perrone has served on numerous regional and national task forces and advisory committees with the CDC and FDA addressing judicious opioid use and has advocated at the state and national level for harm reduction and ED treatment for OUD.  Dr. Perrone is featured in prominent media including the New York Times, National Public Radio and USA Today and has published in the New England Journal of Medicine and JAMA . She has won numerous awards for education and mentorship of students, residents and fellows and is boarded in emergency medicine, medical toxicology and addiction medicine.

Jessica Merlin, MD
University of Pittsburgh

Dr. Merlin is an Associate Professor in the division of General Internal Medicine and section of Palliative Care and Medical Ethics at the University of Pittsburgh (Pitt) and Director of Pitt’s CHAllenges in Managing and Preventing Pain (CHAMPP) clinical research center. She is a physician and is board certified in internal medicine, infectious disease, palliative care, and addiction medicine. She is also a PhD-trained behavioral scientist and NIH-funded clinician-investigator. Her program of research focuses on the intersection of chronic pain and opioid misuse/use disorder across populations and settings, especially in individuals with serious illnesses like advanced cancer. To that end, she is the MPI of the NIH-funded Tailored Retention and Engagement for Equitable Treatment of Opioid use disorder and Pain (TREETOP) clinical research center, one of four NIH-funded centers focusing on the intersection of pain and opioid use disorder in the US, and the MPI of an R01 to investigate opioid benefits, risks, and decision making in individuals with advanced cancer. Her work in this area is widely published, and she serves as a scientific mentor to many PhD students, post-doctoral fellows, and faculty with similar interests. Clinically, she co-directs the Palliative Recovery Engagement Program, a palliative care clinic embedded in an office-based addiction treatment program, where she sees patients with serious illness, particularly advanced cancer, who also have pain and opioid misuse/use disorder. She has been recognized nationally with a Sojourn Scholars Leadership Award from the Cambia Health Foundation, and with research awards American Academy of Hospice and Palliative Medicine, American Pain Society, and Association for Multidisciplinary Education and Research in Substance use and Addiction. She was recently awarded the 2022 Society of General Internal Medicine Mid-Career Research Mentorship award.

Brandon Marshall, PhD
Brown University School of Public Health

Dr. Marshall is a professor of epidemiology at the Brown University School of Public Health. He is also founding director of the People, Place & Health Collective at Brown University. Dr. Marshall’s research focuses on substance use epidemiology, with a specific emphasis on harm reduction and overdose prevention. He is passionate about conducting research that improves the health and well-being of people who use drugs.
Summary
Availability: Retired
Cost: FREE
Credit Offered:
No Credit Offered
Contains: 7 Courses
Recommended
Powered By